MARCo Health offering is now closed and is no longer accepting investments.
INVEST IN MARCO HEALTH TODAY!
Accessible mental healthcare via compassionate robots
$60,614.78 Raised
Reasons to Invest
- We are one of the very few companies on the market to offer a physical robot for in-person care to our target demographic, focusing on five tracts of mental health interventions.
- As of 2021, the global investment in mental health technology has climbed to 139% YoY (source). Adding to that, the virtual care industry has grown to 38 times its pre-pandemic levels (source).
- Our team has a combined 45+ years of experience in robotics and medical devices, and our CEO was the lead engineer for a US Navy robot. Additionally, we have raised $175K from investors, and have been awarded over $30K from a combination of prize funds and grants.
OVERVIEW
Meet MARCo - Your Mental-Health Assisting Robot Companion
MARCo Health believes that everyone should have access to a counselor, advocate, or someone just willing to listen - 24 hours a day, 7 days a week. With the help of MARCo, we are striving to help millions of individuals in need of mental health support. Because to us, no one should feel alone and have to wait to feel better.
MARCo leverages state-of-the-art AI technology to have conversations with users and provide personalized care through five proven forms of therapy: Companionship, Biofeedback, Talk Support, Guided Meditation & Relaxation, and High Alert Outreach.
THE PROBLEM & OUR SOLUTION
MARCo aims to bridge the gap between the lack of mental health professionals and the shortcomings of existing technologies
One-third of young adults struggle with mental health disorders every year, but less than half receive any mental health care (source). Although there are mental health apps out there, they don’t provide that in-person opportunity to connect.
*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success.
By serving as an AI-enabled “someone to talk to” with a physical presence, MARCo simulates the much desired need for an in-person interaction, available 24/7 - at a fraction of the cost of traditional therapy. Utilizing evidence-based therapies including Cognitive Behavioral Therapy, Mindfulness, and Behavioral Activation, MARCo personalizes care with hundreds of different activities that fall under five broader categories.
We generate revenue through both D2C and B2B streams, based on the sales of our robots and subscriptions to our software - which may be bundled with a purchase of our robots.
THE MARKET & OUR TRACTION
Because of COVID-19, the market size for mental health solutions is increasing rapidly
20% of the US population experienced a significant negative impact on their mental health from the pandemic (source). Global investments in the mental health technology sector jumped 139% from $2.3 Billion in 2020 (source), and the virtual care industry has grown to 38 times its pre-pandemic levels (source).
*The above information is based on internal research.
The growing need for mental health treatment options has fast-tracked the FDA’s authorization of “digital therapeutics” to be brought to market without needing FDA review. Although there are a growing number of virtual chatbot therapists, we have not seen our competition implement long-form conversations - a key customer need - nor do they utilize physical robots.
Not only was the need for a physical companion a frequent request from customer interviews, but an internal study spanning almost two years showed us that a physical companion outperforms an app-only companion across several key business and care metrics.
*The above information is based on internal research.
We also believe our initial focus on care for teens and young adults in the US, which has a total addressable market estimated to be $21.2 Billion, differentiates us from our app-based competitors, which we have seen target primarily older adults.
With all this, we truly believe the market needs MARCo. Here’s how we are getting there:
- Launched a new model of our robot at a consumer friendly price point to launch to our D2C market (source)
- Scaled internationally with our first international sale to the U.K. and the addition of an exclusive, pan-Asia distributor with the India-based mental health company TransformHappily (source).
- Completed the “What If Fellowship” mental health accelerator program
- Developed clinical research partnership with Hamilton Labs - a youth suicide prevention lab based out of Rutgers University
We generate revenue through both D2C - via online e-commerce - and B2B - via direct sales to private and school-funded counseling practices streams, based on the sales of our robots and subscriptions to our software - which may be bundled with a purchase of our robots.
*Revenue as of September 2022
WHY INVEST
Our vision is a world where no one in a mental health crisis has to wait for care
In our view, cost, stigma, privacy concerns, mistrust, lack of availability, or any other reason should not prevent someone from getting the mental health care they need. We believe that cost-effective, 24/7 accessible, AI-enabled robot companions are a major step towards a brighter future.
Don’t just take our word for it! Hear it straight from the mouths of those MARCo has helped already:
*The above testimonials may not be representative of the experience of other customers.
*The above testimonials may not be representative of the opinions of other medical experts and is not a guarantee of future performance or success.
With near zero advertising spend, we are already getting more organic orders than we can produce.
*These are historical figures & do not guarantee future performance or success.
An investment at this stage would enable us to push towards more accessible, effective mental healthcare by scaling our production and marketing efforts to meet the high demand we are seeing.
Invest today, and help us on our mission to bring more companionship to the world with MARCo.
ABOUT
HEADQUARTERS
112 Large Avenue
Hillsdale, NJ 07642
VALUATION
$7.72M
MARCo Health is aiming to combat the mental health crisis through our flagship therapeutic robot MARCo - the Mental-Health Assisting Robot Companion. Our goal is to provide individuals struggling with depression, anxiety, stress, and other mental health issues, with 24/7 access to their own private, personalized care through affordable, accessible, and, yes, adorable, mental wellness companions. We have already achieved over $27K in sales, performed early-stage clinical trials, launched a mobile app with thousands of users, and distributed robots across North America, Europe, and Asia. MARCo is patented in the US, patent number 11439346.
TEAM
Jacob Boyle
CEO, CTO, President, and Director
Attiq Amjad
CMO & Director
Dr. Nithin Krishna
Chief Clinical Officer
Dr. Nigam Samal
Acting CTO
Tina Mulligan
Customer Success Manager
John Byrne
Healthcare & Business Valuation Specialist/ M&A Advisor/ CPA ABV
TERMS
MARCo Health
Overview
PRICE PER SHARE
$5
DEADLINE
Dec 30, 2022
VALUATION
$7.72M
AMOUNT RAISED
$60,614.78
Breakdown
MIN INVESTMENT
$250.00
MAX INVESTMENT
$1,235,000.00
MIN NUMBER OF SHARES OFFERED
2,000
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
247,000
Maximum Number of Shares Offered subject to adjustment for bonus shares
Company | : | MARCo Health, Inc |
Corporate Address | : | 112 Large Avenue, Hillsdale, NJ 07642 |
Offering Minimum | : | $10,000.00 |
Offering Maximum | : | $1,235,000.00 |
Minimum Investment Amount(per investor) | : | $250.00 |
Terms
Offering Type | : | Equity |
Security Name | : | Common Stock |
Minimum Number of Shares Offered | : | 1,953 |
Maximum Number of Shares Offered | : | 241,211 |
Price per Share | : | $5.00 |
Pre-Money Valuation | : | $7,680,000.00 |
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives & Bonuses*
Audience-Based:
5% bonus shares for returning investors/supporters
Time-Based:
Friends and Family Early Birds
Invest $250 within the first 72 hours and receive 20% bonus shares
Super Early Bird Bonus
Invest $250 within the first week and receive 15% bonus shares
Early Bird Bonus
Invest $250 within the first two weeks and receive 10% bonus shares
Amount-Based:
$500+ | MARCo’s Sponsor
Invest $500+ and get a MARCo swag combo + 2 years free access to the MARCo app + 5% bonus shares
$1,000+ | MARCo’s Friend
Invest $1000+ and get a 15% off the price of any MARCo + 4 years free access to the MARCo app + a MARCo swag combo + 5% bonus shares
$2,500+ | MARCo’s Bestie
Invest $2500+ and get 50% off the price of any MARCo + lifetime access to the MARCo app + a MARCo swag combo + 8% bonus shares
$5,000+ | MARCo’s Hero
Invest $2500+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares
$10,000+ | MARCo’s #1 Fan
Invest $10,000+ and get a fully customized MARCo (e.g., your choice of color, design) + MARCo swag combo + 4 x lifetime access to the MARCo app + 15% bonus shares
The 10% StartEngine Owners' Bonus
MARCo Health will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $5.00/ share, you will receive 110 shares Common Stock, meaning you'll own 110 shares for $500. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus 5% returning supporter's bonus in addition to the aforementioned bonus.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Salary payments made to one’s self, a friend or relative.
PRESS
ALL UPDATES
12.30.22
Campaign Closed | Our Community Joined In! | Insider Investment Notice
Hello all MARCo Friends and Followers!
And that's a wrap! Our first ever equity crowdfunding campaign closed at 11:59 PM last night. The amount of support will make a huge impact on our planned goals for this coming year.
We are grateful to all of our investors and backers in this campaign who believed in us enough to push forward the future of mental healthcare.
And we were excited to see our community come in and invest in MARCo Health!
Our Insiders have invested a total of $11,550 into the offering to date!
Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.
If you are interested in receiving further updates in our progress moving forward, please stay tuned for updates from our campaign here, and you can also get direct email updates or have all of your future questions answered through our investor email, investors@marcohealthtech.com
Stay tuned for the next steps in the future of MARCo!
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.30.22
LAST CHANCE - CAMPAIGN CLOSING SOON
Hello MARCo friends and followers,
This is the final campaign update before the close of our campaign at 11:59 PM tonight.
We have been thrilled by the outpouring of support we've seen in our campaign, and we are grateful to everyone who has invested so far for believing in our mission and joining us in our vision of affordable, accessible, and higher quality mental healthcare for all through MARCo.
But our campaign isn't over yet, and if you haven't gotten in, this is the last chance to invest in the future of mental healthcare during this campaign.
If you have tried to invest and are having issues, as some of our investors have faced, please comment on our campaign or email us directly at hello@marcohealthtech.com so we can help you resolve any barriers to investment as fast as possible.
For all those following our campaign thus far, we hope you will make the choice to invest in our campaign before it closes tonight and help us close out 2022 on a high note. And for all of those who have already invested, thank you again from all here at MARCo Health Inc.
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.29.22
Campaign Closes Today!
Hello MARCo Friends and Followers!
We are nearing the end of our campaign here on StartEngine - less than 24 hours left to go! Our campaign is set to close today Thursday, December 29th at 11:59 PM EST, and we will not be extending this campaign past that deadline.
We are looking ahead to next year and all the incredible opportunities we have ahead of us:
- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year
- Launching clinical and human factor studies with partnering psychiatric and therapy partners
- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest
- Continuing research in MARCo's advanced AI which we believe serves as the basis for future publishable research papers and/or further patents
- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these organizations, means we believe we can submit and earn multiple government grants and contracts next year
- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023
- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch
- A lower cost MARCo we intend to launch in 2023 based on immense (and growing) consumer interest in such a product
To accomplish these goals and many, many more, we are looking for a strong close to our StartEngine campaign. So I humbly ask, if you have not already, please consider investing as this is the last chance you will have for this campaign. And if you cannot at this time, please share our campaign and our mission with anyone you can so we can grow our vision of affordable, accessible, quality mental healthcare for all into a global reality.
We hope that, if you have not already, you will join us in our mission and help us reshape the narrative of our world's global mental health epidemic into one of innovation, hope, and care.
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.27.22
2 Days Remaining - Last Chance to Get In!
Hello MARCo Friends and Followers!
We are nearing the end of our campaign here on StartEngine! As a quick reminder, our campaign is set to close on this Thursday, December 29th at 11:59 PM EST, and we will not be extending this campaign past that deadline.
While it has been an exhilarating and wonderful experience launching and running our first equity crowdfunding campaign, we have chosen not to extend so we can focus our full team effort onto the incredible opportunities we believe we have ahead for our company:
- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year
- Launching clinical and human factor studies with partnering psychiatric and therapy partners
- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest
- Continuing research in MARCo's advanced AI which we believe serves as the basis for future publishable research papers and/or further patents
- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these organizations, means we believe we can submit and earn multiple government grants and contracts next year
- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023
- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch
- A lower cost MARCo we intend to launch in 2023 based on immense (and growing) consumer interest in such a product
To accomplish these goals and many, many more, we are looking for a strong close to our StartEngine campaign. So I humbly ask, if you have not already, please consider investing as this is the last chance you will have for this campaign. And if you cannot at this time, please share our campaign and our mission with anyone you can so we can grow our vision of affordable, accessible, quality mental healthcare for all into a global reality.
We hope that, if you have not already, you will join us in our mission and help us reshape the narrative of our world's global mental health epidemic into one of innovation, hope, and care.
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.22.22
Happy Holidays from MARCo Health!
Hello MARCo Friends and Followers!
We at MARCo Health wish you a happy holiday season, whether you formally celebrate Christmas or Hanukkah or you just observe a holiday weekend off from work!
We know this time of year can be stressful - just look at MARCo above - and overwhelming between gifts, travel plans, weather, and either being overwhelmed with family or isolated from loved ones. So remember that, even though it is the season of giving and focusing on others, don't forget to take care of yourself.
For all of you who have joined in on our campaign so far, we just want to say, your support has been the greatest gift we've received this holiday season. For those who are still contemplating joining in on our campaign, this is the time to do it as our campaign closes on December 29th at 11:59 PM. Every investment goes a long way with us to bring the future of mental healthcare out into the world, so we hope that if you are still debating joining in, you make the decision to join us in our mission and our work.
Have a happy, safe, healthy, and merry holiday from all of us here at MARCo Health Inc!
Best Regards,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.19.22
Just Under Two Weeks Left In Campaign!
Hello MARCo friends and followers,
We are coming in on the planned close of our campaign! December 29th, 2022 at 11:59 PM will be the last opportunity to join our movement of revolutionizing mental healthcare and invest in MARCo Health in this crowdfunding offering.
If you have been following us thus far and haven't invested yet, this is the perfect time to join in. As we close out 2022, we are riding a wave of incredible momentum on fantastic opportunities into 2023:
- Multiple hospital networks in the pipeline for pilot programs which we believe will launch next year
- Our Amazon and eCommerce listings picking up steam and order deliveries across the US with international interest
- Multiple first meetings and grant/contract presubmissions with program officers with the NIH, NSF, and DoD which, based on positive reception from these orginizations, means we believe we can submit and earn multiple government grants and contracts next year
- FDA presubmission in process for a first meeting with the FDA estimated to happen in January 2023
- Growing production with suppliers lined up to manufacture higher volume units in quantities of 500-10000 per batch
- A lower cost MARCo we intend to launch in 2023 based on consumer interest in such a product
But for these initiatives and many more we have lined up, we need the backing of our supporters. Please consider investing in our campaign to help us make our vision of affordable, accessible, and high quality mental healthcare for all possible. And if you cannot invest, share, spread the word, and forward our campaign to others you think believe in our mission and want to join in our successes.
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.12.22
CEO Featured In Brainz 500
Hi MARCo friends and followers,
We got some exciting news this morning! Our CEO has been featured in the Brainz Magazine Brainz 500 list! You can check out the official honoree page here:
https://www.brainzmagazine.com/brainz-500-global-2022/jacob-boyle
The Brainz 500 honorees represent 500 of the best companies and influential leaders in the business of helping others on a global scale. The list features CEOs and thought leaders across the health, wellness, psychology, relationship, and entrepreneurial achievement spheres. Some other notable names on this list include Marc Randolph Co-founder and first CEO of Netflix, Marissa Peer World-renowned therapist and best-selling author, and Vishen Lakhiani Founder & CEO, Mindvalley, although you can see the whole list here.
We are humbled to receive this recognition for our work, and we take it as yet another reminder that the work we are doing is worth pursuing.
But no matter how hard we pursue our goals of affordable, accessible, quality mental healthcare for all, we still need the backing of MARCo supporters to accomplish these goals, so we are humbly asking that you join us on our journey. Even if you can't invest, spread the word, share our story, and help us close out our campaign, and this year, with an enormous showing of support.
Sincerely,
The MARCo Health Team
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
12.09.22
3 Weeks Until Campaign Closes!
Hello MARCo Friends and Followers!
Happy December everyone! We are closing in on the end of our campaign - December 30th is the last day of our campaign. We are thrilled with the outpouring of support we've received so far, and we are also excited to close out this campaign strong!
But we need your help! If you have been following us and waiting to invest, this is the perfect time to get in on the future of mental healthcare. We are looking for a strong push at the end of this campaign to close out 2022 on a high note and push straight into the opportunities we have planned for the very start of 2023.
In Q1 of 2023, we intend to file our presubmission for FDA clearance with the FDA, apply to multiple SBIR grants with the NIH and NSF to further MARCo research, scale MARCo production to hundreds of units, and launch pilot programs at a number of hospitals and health networks that are currently in our funnel.
But we need the backing of MARCo supporters to accomplish these goals, so we are humbly asking that you join us on our journey. Even if you can't invest, spread the word, share our story, and help us close out our campaign, and this year, with an enormous showing of support.
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
11.23.22
MARCo Featured in Brainz Magazine!
Hello MARCo Friends and Followers!
We've got some exciting news! MARCo just got featured in Brainz magazine - a leading global publication on psychology, neuroscience, and the entrepreneurs + tech that bring these fields into the future. You can read the article here:
Not only that, but Brainz Magazine has told us that we were nominated to the Brainz 500 for induction into their December cohort of winners - think Forbes 500 but specifically for mental health tech companies. So everyone keep their fingers crossed (and MARCo will keep its mittens crossed) that we'll be selected next month for this prestigious award!
Our team members have been picked up on a number of podcasts and interviews recently as well, so be sure to follow this campaign if you haven't already to see the latest and greatest of MARCo making headlines!
And to all our backers, I want to say again, thank you for joining our mission. If you want to see your impact and investment go even further, please make sure to share our company and campaign with anyone and everyone you may know who may be interested. And even if you are just following for now, a share can go a long way, so please do consider sharing and spreading the word.
Thank you all and stay tuned for the next latest and greatest update in MARCo's journey!
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
11.18.22
MARCo Takes First Step Towards FDA Clearance
Hello all MARCo friends and followers,
We are very excited to share that we are taking the first steps towards our ultimate goal of an FDA cleared MARCo product. We recently engaged with an FDA consultancy firm - FDA Consultants - with over 30 years of experience in successfully navigating companies through FDA medical device applications from start to finish. Our first project with them will be completing an FDA Q-Submission, which we believe we can submit and have our first formal meeting with an FDA panel of experts by the end of this calendar year.
The results of that Q-Submission will cement our path forward to bringing MARCo to regulatory clearance in the U.S. We believe the results of the meeting and feedback from the FDA will enable us to identify whether MARCo has enough of a predicate to go for a traditional classification, if it is so cutting edge that it would go through a DeNovo pathway and forge its own classification, or if it can earn breakthrough device status - a status which would open up additional government funds for our company. Given previous research on existing classifications, we currently believe we have a path to breakthrough device status.
Based on previous work the FDA Consultants have done, as well, we believe that we can achieve FDA clearance in 12-18 months from now. This is based on previous successes of the consultancy firm as well as industry standards.
Why is FDA clearance needed if we're on the market?
While we will continue to sell our wellness & support version of MARCo, we believe FDA clearance will be key to unlocking MARCo's ultimate growth potential. First, FDA clearance is a required step to get MARCo covered by insurance and other medical payment plans. Second, it would enable us to bring MARCo to higher risk customers and larger institutions whose focus is on high risk individuals - a core part of our mission. Combined, we believe that the increase in target market size and insurance coverage abilities will enable us to grow sales and build a more legitimate brand.
We will keep you all posted as we continue on this FDA clearance journey!
And to all our backers, I want to say again, thank you for joining our mission. If you want to see your impact and investment go even further, please make sure to share our company and campaign with anyone and everyone you may know who may be interested. And even if you are just following for now, a share can go a long way, so please do consider sharing and spreading the word.
Thank you all and stay tuned for the next latest and greatest update in MARCo's journey!
Sincerely,
Jacob Boyle
CEO - MARCo Health Inc.
Website: https://www.marcohealthtech.com
Facebook: https://www.facebook.com/marcohealthtech
Instagram: @marcotherobot
TikTok: @marcotherobot
LinkedIn: https://www.linkedin.com/company/marco-technologies-llc/
Stack Owner's Bonus & Rewards!
Members get an extra 10% shares in addition to rewards below!
REWARDS
$250.00
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$500.00
$500+ | MARCo’s Sponsor
Invest $500+ and get a MARCo swag combo + 2 years free access to the MARCo app + 5% bonus shares
$1,000.00
$1,000+ | MARCo’s Friend
Invest $1000+ and get a 15% off the price of any MARCo + 4 years free access to the MARCo app + a MARCo swag combo + 5% bonus shares
$2,500.00
$2,500+ | MARCo’s Bestie
Invest $2500+ and get 50% off the price of any MARCo + lifetime access to the MARCo app + a MARCo swag combo + 8% bonus shares
$5,000.00
$5,000+ | MARCo’s Hero
Invest $5000+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares
$5,000.00
$5,000+ | MARCo’s Hero
Invest $5,000+ and get a free MARCo of your choice + 2 x lifetime access to the MARCo app + a MARCo swag combo + 10% bonus shares
$10,000.00
$10,000+ | MARCo’s 1 Fan
Invest $10,000+ and get a fully customized MARCo (e.g., your choice of color, design) + MARCo swag combo + 4 x lifetime access to the MARCo app + 15% bonus shares
JOIN THE DISCUSSION
0/2500
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
